Articles tagged "Outcome"

2018 American Transplant Congress
Complications and QoL after Living Donor Hepatectomy: Analysis of 176 Cases at a Single Center
S. Chinnakotla, V. Kirchner, S. Mongin, D. Berglund, O. Serrano, T. Pruett.
Department of Surgery, University of Minnesota, Minneapolis.
Background: Living liver donation is one of the most selfless and humane acts a person can perform. Few single-center reports have been published specifically evaluating…
2018 American Transplant Congress
Secular Trends in the Medical Complexity and Outcomes of Medicare-Insured Patients Undergoing Kidney Transplant
C. Lenihan,¹ S. Liu,¹ M. Montez-Rath,¹ W. Winkelmayer.²
¹Stanford University, Palo Alto, CA; ²Baylor College of Medicine, Houston, TX.
Graft and patient survival following kidney transplant (KT) are improving. The reasons for this trend are unclear. We set out to examine concurrent changes in…
2018 American Transplant Congress
Post‐Donation eGFR Levels Predicts New‐Onset Antihypertensive Medication Use after Living Kidney Donation
K. Lentine,¹ D. Segev,² N. Lam,³ A. Garg,⁴ A. Naik,⁵ D. Axelrod,⁶ H. Xiao,¹ M. Henderson,² A. Massie,² B. Kasiske,⁷ G. Hess,⁸ C. Hsu,⁹ D. Brennan,² M. Schnitzler.¹
¹Saint Louis Univ, St. Louis; ²Johns Hopkins, Baltimore; ³Univ Alberta, Edmonton, Canada; ⁴Western Univ, Ontario, Canada; ⁵Univ Michigan, Ann Arbor; ⁶Lahey Clinic, Burlington; ⁷Hennepin County, Minneapolis; ⁸Symphony Health, Conshohocken; ⁹UCSF, San Francisco.
Limited data are available on the outcome implications of renal function after living kidney donation.We constructed a novel database linking SRTR registry identifiers, serum creatinine…
2018 American Transplant Congress
A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes
J. Friedewald,¹ S. Kurian,² T. Whisenant,² R. Heilman,³ E. Poggio,⁴ C. Marsh,² P. Baliga,⁵ N. Bridges,⁶ J. Odim,⁶ M. Brown,⁶ D. Ikle,⁷ B. Armstrong,⁷ J. Charette,¹ S. Brietigam,¹ N. Sustento-Reodica,¹ L. Zhao,¹ M. Kandpal,¹ D. Salomon,² M. Abecassis.¹
¹Northwestern Medicine, Chicago; ²Scripps, La Jolla; ³Mayo AZ, Scottsdale; ⁴Cleveland Clinic, Cleveland; ⁵MUSC, Charleston; ⁶NIAID, Bethesda; ⁷Rho, Chapel Hill.
BACKGROUNDSub-clinical acute rejection (subAR) in kidney transplant recipients (KTR), defined as histological rejection on surveillance biopsy (Bx) in a patient with stable renal function, signals…
2018 American Transplant Congress
Tuberculosis among Kidney Transplant Patients Compared to Dialysis and Non-Dialysis CKD Patients over a Decade Period
A. Metry, I. Al Salmi, F. Al Ismaili, A. Hola, F. Shaheen, I. Al Salmi.
The Renal Medicine, The Royal Hospital, Muscat, Oman; The Renal Medicine, The Royal Hospital, Muscat, Oman; The Renal Medicine, The Royal Hospital, Muscat, Oman; The Renal Medicine, The Royal Hospital, Muscat, Oman; SCOT, SCOT, Riyadh, Saudi Arabia; The Renal Medicine, The Royal Hospital, Muscat, Oman.
USRDS showed that 1.2% & 1.6% incidences of tuberculosis-TB in patients on peritoneal dialysis and hemodialysis-HD, respectively. Kidney transplant-KTX patients have higher rates.We studied the…
2018 American Transplant Congress
Liver Allocation: One OPO's Experience with Expedited versus Non-Expedited Placement
C. Muse, R. Squires, C. Trahan, J. Whaley, J. Orlowski.
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK.
Background: One organ procurement organization (OPO) sought to study expedited versus non-expedited livers recovered/transplanted after local/regional centers declined. The OPO sought to determine relative recipient…
2018 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation
T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health BIH, Charite and Max Delbrueck Center, Berlin, Germany.
Despite rapid medical advancements in the field of transplantation, mean allograft survival remained at a standstill. If and to what extent a highly specialized and…
2018 American Transplant Congress
Heart Transplantation in Patients with Complex Congenital Heart Disease
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa, R. Garg, E. Zahn.
Cedars Sinai Medical Center, Los Angeles.
Purpose: As medical and surgical management of complex congenital heart disease (CCHD) improves, patients may survive into adulthood to suffer from end-stage heart failure and…
2018 American Transplant Congress
A Mobile App to Improve Medication Adherence in Kidney Transplant Recipients – Analysis of a Prospective Interventional Study
F. Halleck, S. Georgi, D. Khadzhynov, D. Schmidt, E. Schrezenmeier, L. Lehner, P. Glander, K. Budde, O. Staeck.
Department of Nephrology and Medical Intensive Care, Charité University Berlin, Berlin, Germany.
Background: Non-adherence to medication is one of the leading problems for poor long-term outcome in kidney transplant recipients (KTR). Here we analyze the impact of…
2018 American Transplant Congress
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease
E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
NYU Langone Medical Center, New York, NY.
Objective: Peripheral vascular disease (PVD) is common among end-stage renal disease (ESRD) patients and is a known independent risk factor for increased post-transplant mortality. The…